{"ticker": {"uuid": "a9b49449-c471-4c0c-ab4a-e31097c3707e", "symbol": "4577", "name": "Daito Pharmaceutical Co.,Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Daito Pharmaceutical Completes \u00a5605 Million Share Buyback to Boost Capital Efficiency", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQLV9RczlUbDJvSEhfN0RWRXRHSnRlRVFhOEQtcU5MbEJZQUVEckItUG5mTFdEdlZqSHJhZkRYR25CdHdBamh3Y1NKMEEzRjhvdGQ0SkdFbkdfbklSRnVZX3lWYTFxdEZfUkkwWl9LcWJuM2x4enBJSGxQZUxXc0xmWlcwcGYzMmZRVGNqQmJBeGItMHVIQlF3b2hlNTNPUk9kYzhvZTJpZy1ITFNfb1htV3N5YXRpcHk4QTJPalgtSE1DMWxVSkY4ek0yVmFqMXpRTmc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T02:28:02+00:00", "published_display": "13 Jul 2026 02:28", "sentiment": "positive", "sentiment_pct": 62, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 500,000 shares, representing 1.73% for \u00a5625 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNbGdNLTNWenB2aWpxNjNQeTBWS2RHR3RvRy1RTDNyNm9IeDM3eVJyVFJOOXRUNlhKSHRlXzRqNzZzTExGdWhGemdHZVpUeXVDWHVoTTQ5ZzRqcG9pYWZFVVZpck5NOTdYV3BMaHhvNzkyR1B2NEJHZ3laRUp6V3N0QnA4ekcxWWNvSE9jQ3RBc2xHVHR4Vm9YQVBOUGpCRHo1V1pKenNmVHpmMjg5UG43Z1VtdHQ0RG02cm1DMHZjVXFwLUxiWDRVNHdkV0J2NUVYSEROa1J3bmxScDFBOFptVHdrbw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T15:42:55+00:00", "published_display": "10 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daito Pharmaceutical Overhauls Board and Executive Structure to Bolster Governance and Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOaXU3NXBTOVFIQWMtSVM1bDJTQVRYbFhtN1NmSTNZV1czUnNIRV9YejhhYjUyeXRFSmhpcU96VUJyRUN2eG5Rbm9SVTR3SDI3dmFlVGh2bS1JV240OGtWQ0g0dzl5Y2ZnRUpENWNpZVB6Y0R5QlhsRm1aUnBuVWNiUERwV3FlUTkyZmVKRVg2N0VWWXlPaGljZjZwbmJlbVEtMnVkQVVadnV3YlFSYldaQ0RPMXdpdHg1TG1fSkkteGh0aUtua0VsSXR4VTMzTmJCWTRtWjJCVTZQX2ppQWc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T07:54:19+00:00", "published_display": "10 Jul 2026 07:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Daito Pharmaceutical Co., Ltd. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE0xeU1iZkYtdElXRk5McVd6LXpSTjd6aXM1RHdFUE5iN0hJVjg0REVSZmh2UkdUVHg4azF4c3VwcTRKbWx1ZzZiSHJBcXBnMF9kUTROZndqSGFPRThxQlpr?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T01:02:33+00:00", "published_display": "09 Jul 2026 01:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Daito Pharmaceutical Co., Ltd. \u2013 TSE:4577", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdUtXXzRuR3hVaWs2dHVVdWF4YkM0OEVFTWRMQWFibUQzTFZaU1hWOWJ1a0pNek5KQWQ1LTlZdVIxbTBBeUlDRENWbXZWY2RGRHBST3FXR25pdHVBelNhb182c1VRUnZFRmxqT3lCZjNDaGpuSVZYek9xaEtRWmZSamJaVERRUUlILXg1UWNrNHExRnh4cnprWlBjZWZVdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T02:18:05+00:00", "published_display": "04 Jul 2026 02:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Daito Pharmaceutical Completes \u00a5605 Million Share Buyback to Boost Capital Efficiency", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQLV9RczlUbDJvSEhfN0RWRXRHSnRlRVFhOEQtcU5MbEJZQUVEckItUG5mTFdEdlZqSHJhZkRYR25CdHdBamh3Y1NKMEEzRjhvdGQ0SkdFbkdfbklSRnVZX3lWYTFxdEZfUkkwWl9LcWJuM2x4enBJSGxQZUxXc0xmWlcwcGYzMmZRVGNqQmJBeGItMHVIQlF3b2hlNTNPUk9kYzhvZTJpZy1ITFNfb1htV3N5YXRpcHk4QTJPalgtSE1DMWxVSkY4ek0yVmFqMXpRTmc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T02:28:02+00:00", "published_display": "13 Jul 2026 02:28", "sentiment": "positive", "sentiment_pct": 62, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 500,000 shares, representing 1.73% for \u00a5625 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNbGdNLTNWenB2aWpxNjNQeTBWS2RHR3RvRy1RTDNyNm9IeDM3eVJyVFJOOXRUNlhKSHRlXzRqNzZzTExGdWhGemdHZVpUeXVDWHVoTTQ5ZzRqcG9pYWZFVVZpck5NOTdYV3BMaHhvNzkyR1B2NEJHZ3laRUp6V3N0QnA4ekcxWWNvSE9jQ3RBc2xHVHR4Vm9YQVBOUGpCRHo1V1pKenNmVHpmMjg5UG43Z1VtdHQ0RG02cm1DMHZjVXFwLUxiWDRVNHdkV0J2NUVYSEROa1J3bmxScDFBOFptVHdrbw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T15:42:55+00:00", "published_display": "10 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daito Pharmaceutical Overhauls Board and Executive Structure to Bolster Governance and Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOaXU3NXBTOVFIQWMtSVM1bDJTQVRYbFhtN1NmSTNZV1czUnNIRV9YejhhYjUyeXRFSmhpcU96VUJyRUN2eG5Rbm9SVTR3SDI3dmFlVGh2bS1JV240OGtWQ0g0dzl5Y2ZnRUpENWNpZVB6Y0R5QlhsRm1aUnBuVWNiUERwV3FlUTkyZmVKRVg2N0VWWXlPaGljZjZwbmJlbVEtMnVkQVVadnV3YlFSYldaQ0RPMXdpdHg1TG1fSkkteGh0aUtua0VsSXR4VTMzTmJCWTRtWjJCVTZQX2ppQWc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T07:54:19+00:00", "published_display": "10 Jul 2026 07:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Daito Pharmaceutical Co., Ltd. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE0xeU1iZkYtdElXRk5McVd6LXpSTjd6aXM1RHdFUE5iN0hJVjg0REVSZmh2UkdUVHg4azF4c3VwcTRKbWx1ZzZiSHJBcXBnMF9kUTROZndqSGFPRThxQlpr?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T01:02:33+00:00", "published_display": "09 Jul 2026 01:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Daito Pharmaceutical Co., Ltd. \u2013 TSE:4577", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdUtXXzRuR3hVaWs2dHVVdWF4YkM0OEVFTWRMQWFibUQzTFZaU1hWOWJ1a0pNek5KQWQ1LTlZdVIxbTBBeUlDRENWbXZWY2RGRHBST3FXR25pdHVBelNhb182c1VRUnZFRmxqT3lCZjNDaGpuSVZYek9xaEtRWmZSamJaVERRUUlILXg1UWNrNHExRnh4cnprWlBjZWZVdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T02:18:05+00:00", "published_display": "04 Jul 2026 02:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 5, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 3, "score": 56, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "capital_return", "primary_label": "Capital return", "confidence": 62, "events": [{"event": "capital_return", "label": "Capital return", "weight": 1.1, "count": 2}, {"event": "general", "label": "Market update", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1250.0, "latest_week": "2026-07-10", "one_week_move": 0.3, "four_week_move": 3.4, "twelve_week_move": -6.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.766071, "market_dynamics_buy_signal": false, "relative_strength": -24.737033, "fair_value_gap": 14.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 56.9705, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.3% over one week, +3.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Capital return", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Capital return", "count": 2}, {"label": "Market update", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Capital return", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.3% over one week, +3.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Daito Pharmaceutical Completes \u00a5605 Million Share Buyback to Boost Capital Efficiency"}], "updated_at": "2026-07-17T16:30:37.034358+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}